Table 3 Social capital and HIV-antiretroviral adherence among people living with HIV
Site | N | Social Capital μ(sd) | Adherence % past 30-day μ(sd) | Adherence 100%a n(%) | Prescribed HIV antiretroviral therapy n(%) |
|---|---|---|---|---|---|
Canada | 100 | 2.54 (0.56) | 84.1 (24.7) | 37 (43.5) | 85 (85) |
Puerto Rico | 100 | 2.74 (0.52) | 88.7 (20.1) | 51 (56) | 91 (91) |
California | 300 | 2.53 (0.59) | 82.7 (23.2) | 86 (36.8) | 234 (78) |
Hawaii | 100 | 2.73 (0.56) | 89.6 (14) | 32 (35.2) | 91(91) |
Illinois | 95 | 2.66 (0.59) | 83.4 (24.4) | 29 (36.3) | 80 (84) |
Massachusetts | 200 | 2.67 (0.54) | 84.8 (23.2) | 70 (40.7) | 172 (86) |
New Jersey | 100 | 2.64 (0.48) | 85.1 (21.9) | 36 (43.4) | 83 (83) |
New York | 100 | 2.69 (0.59) | 83 (23.7) | 31 (37.8) | 82 (82) |
North Carolina | 200 | 2.79 (0.55) | 86.1 (19.7) | 78 (43.3) | 180 (90) |
Ohio | 150 | 2.59 (0.52) | 86.1 (20.9) | 53 (41.4) | 128 (85) |
Texas | 228 | 2.64 (0.52) | 89.5 (19) | 109 (55.6) | 196 (86) |
Washington | 200 | 2.54 (0.56) | 85.8 (23.8) | 87 (51.8) | 168 (84) |
Total | 1,873 | 2.63 (0.55) | 85.7 (21.8) | 699 (44) | 1,590 (84.9) |